MAPT and Alzheimer disease: Tau can be phosphorylated and O-GlcNAcylated at the same sites, and O-GlcNAcylation may prevent phosphorylation at key sites [14]; indeed, levels of O-GlcNAc are decreased in AD tissues [125].